Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Toward vocal fold scar mitigation through CRISPR/Cas-9-mediated gene editing of fibroblasts

Award Number: F31DC023096
ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 08/22/2025
PERIOD OF PERFORMANCE END DATE: 08/21/2027

Group Awards By:

View Award Description

Toward vocal fold scar mitigation through CRISPR/Cas-9-mediated gene editing of fibroblasts - ABSTRACT Vocal fold (VF) scarring negatively impacts both voice quality and quality of life, and effective treatments are currently lacking. VF fibroblasts (VFF) play a crucial role in VF scarring, as they are involved in wound healing and the production and remodeling of the VF lamina propria extracellular matrix in response to injury. Recent advances in understanding VFF gene expression have identified a signaling pathway that may contribute to the scar-like phenotype of differentiated VFF, specifically myofibroblasts. This research proposal aims to identify gene targets that could prevent the differentiation of VFF into myofibroblasts, thereby reducing the overproduction of fibrous proteins and excessive cell proliferation that contribute to scarring. The central hypothesis of this proposal is that inhibiting TGF-β signaling pathways will reduce VFF differentiation and proliferation, leading to a gene expression profile and cellular behavior more characteristic of undifferentiated VFF, with a concomitant reduction in fibrosis. We plan to quantify the effects of gene editing in VFF using an in vitro model and perform functional testing to address specific hypotheses. Specifically, we will target two pathways within the TGF-β signaling cascade: SMAD-dependent pathway and PI3K/AKT SMAD-independent pathway. CRISPR/Cas9 technology will be used to knock out specific genes involved in these pathways. After gene editing, we will assess the cellular response using assays for proliferation, differentiation, and collagen contraction, and perform bulk RNA sequencing to examine gene expression changes. This research is the first to apply CRISPR/Cas9 technology to edit VFF, providing genetic control over VFF differentiation in the context of scarring. The proposed study will shed light on the role of these specific genes and pathways in myofibroblast function. Given that no reliable, minimally invasive treatments for VF scarring currently exist, this proposal may reveal novel targets for further investigation and potential therapies for VF scar remediation.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $52,538 )
2025	2025	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Research Related to Deafness and Communication Disorders	002	1	5/23/2025	NEW	$0
2025	2025	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Research Related to Deafness and Communication Disorders	000	1	3/19/2025	NEW	$51,974
2025	2025	UNIVERSITY OF WISCONSIN SYSTEM	21 N PARK ST STE 6301	MADISON	WI	53715	DANE	USA	Research Related to Deafness and Communication Disorders	001	1	5/23/2025	NEW	$564
														Subtotal = $52,538

Grand Total All Awards = $52,538

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Toward vocal fold scar mitigation through CRISPR/Cas-9-mediated gene editing of fibroblasts

Award Number: F31DC023096

ORGANIZATION: NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 08/22/2025

PERIOD OF PERFORMANCE END DATE: 08/21/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer